CSIMarket
 


Siga Technologies Inc  (SIGAQ)
Other Ticker:  
 

Siga Technologies Inc's Quick Ratio

SIGAQ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the forth quarter 2019, Quick Ratio fell to 0.71 below Siga Technologies Inc average.

Within Major Pharmaceutical Preparations industry 386 other companies have achieved higher Quick Ratio than Siga Technologies Inc in forth quarter 2019. While Quick Ratio total ranking in the forth quarter 2019 has deteriorated compared to the prior quarter from 907 to 2157.

Explain Quick Ratio?
How much Cash & cash equivalents SIGAQ´s has?
What are SIGAQ´s Current Liabilities?


SIGAQ Quick Ratio (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Current Liabilities Change -75.94 % 193.55 % - - -
Y / Y Cash & cash equivalent Change 201.94 % 259.69 % - - -
Quick Ratio MRQ 0.71 7.56 10.03 20.76 0.06
SIGAQ's Total Ranking # 2157 # 907 # 135 # #
Seq. Current Liabilities Change 677.69 % 6.05 % 113.67 % -98.63 % 9387.95 %
Seq. Cash & cash equivalent Change -26.81 % -20.06 % 3.18 % 400.14 % -12.81 %



Quick Ratio forth quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 387
Healthcare Sector # 694
Overall Market # 2157


Quick Ratio Statistics
High Average Low
20.76 7.55 0.06
(Sep 30 2018)   (Jun 30 2018)




Financial Statements
Siga Technologies Inc's Current Liabilities $ 92 Millions Visit SIGAQ's Balance sheet
Siga Technologies Inc's Cash & cash equivalent $ 65 Millions Visit SIGAQ's Balance sheet
Source of SIGAQ's Sales Visit SIGAQ's Sales by Geography


Cumulative Siga Technologies Inc's Quick Ratio

SIGAQ's Quick Ratio for the trailling 12 Months

SIGAQ Quick Ratio

(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Current Liabilities TTM Growth -75.94 % 193.55 % - - -
Y / Y Cash & cash equivalent TTM Growth 201.94 % 259.69 % - - -
Quick Ratio TTM 3.12 0.81 0.66 0.4 0.12
Total Ranking TTM # 1882 # 1423 # 1784 # #
Seq. Current Liabilities TTM Growth 677.69 % 6.05 % 113.67 % -98.63 % 9387.95 %
Seq. Cash & cash equivalent TTM Growth -26.81 % -20.06 % 3.18 % 400.14 % -12.81 %


On the trailing twelve months basis SIGAQ Cash & cash equivalent more than doubled by 201.94 % in IV Quarter 2019 year on year, while Current Liabilities more than doubled to $92 millions, this led to increase in in Siga Technologies Inc's Quick Ratio to 3.12, above SIGAQ average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 369 other companies have achieved higher Quick Ratio than Siga Technologies Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2019 from 1423 to 1882.

Explain Quick Ratio?
How much Cash & cash equivalents SIGAQ´s has?
What are SIGAQ´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 370
Healthcare Sector # 640
Within the Market # 1882


trailing twelve months Quick Ratio Statistics
High Average Low
3.12 1.21 0.25
(Dec 31 2019)   (Sep 30 2018)




Companies with similar Quick Ratio in the quarter ending Dec 31 2019, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2019 MRQ Cash & cash equivalentDec 31 2019 MRQ Current Liabilities
Hutchmed china Limited  1.92 $ 217.168  Millions$ 113.101  Millions
Evofem Biosciences Inc   1.91 $ 23.804  Millions$ 12.462  Millions
Skye Bioscience Inc   1.89 $ 1.835  Millions$ 0.971  Millions
Imunon Inc   1.88 $ 14.861  Millions$ 7.895  Millions
Inhibitor Therapeutics Inc   1.86 $ 0.804  Millions$ 0.431  Millions
Myovant Sciences Ltd   1.86 $ 98.888  Millions$ 53.296  Millions
Taiwan Liposome Company Ltd   1.84 $ 34.265  Millions$ 18.612  Millions
Cti Biopharma Corp   1.82 $ 33.666  Millions$ 18.488  Millions
Durect Corp  1.76 $ 64.674  Millions$ 36.768  Millions
Nighthawk Biosciences inc   1.75 $ 14.754  Millions$ 8.435  Millions
Jazz Pharmaceuticals Plc  1.75 $ 637.344  Millions$ 364.490  Millions
Aclaris Therapeutics Inc   1.74 $ 39.078  Millions$ 22.432  Millions
Actinium Pharmaceuticals Inc   1.74 $ 9.304  Millions$ 5.344  Millions
Rigel Pharmaceuticals Inc  1.68 $ 98.078  Millions$ 58.212  Millions
Tg Therapeutics Inc   1.66 $ 140.435  Millions$ 84.449  Millions
Forte Biosciences Inc   1.65 $ 21.821  Millions$ 13.204  Millions
Organogenesis Holdings Inc   1.65 $ 60.174  Millions$ 36.444  Millions
Regulus Therapeutics Inc   1.58 $ 34.121  Millions$ 21.598  Millions
Regeneron Pharmaceuticals Inc   1.53 $ 3,214.300  Millions$ 2,096.600  Millions
Ampio Pharmaceuticals inc   1.52 $ 6.532  Millions$ 4.284  Millions
Dar Bioscience Inc   1.50 $ 4.780  Millions$ 3.182  Millions
Vbi Vaccines Inc  1.49 $ 44.213  Millions$ 29.757  Millions
Prophase Labs Inc   1.46 $ 1.360  Millions$ 0.933  Millions
Sellas Life Sciences Group Inc   1.45 $ 7.377  Millions$ 5.073  Millions
Dicerna Pharmaceuticals Inc   1.44 $ 348.881  Millions$ 241.735  Millions
Salarius Pharmaceuticals inc   1.43 $ 3.739  Millions$ 2.611  Millions
Pulmatrix Inc   1.42 $ 23.440  Millions$ 16.525  Millions
Aeterna Zentaris Inc   1.39 $ 7.838  Millions$ 5.659  Millions
Alkermes Plc   1.37 $ 534.979  Millions$ 391.112  Millions
Reviva Pharmaceuticals Holdings Inc   1.34 $ 0.134  Millions$ 0.100  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com